DSY.PA Dassault Systèmes EURONEXT 09 Feb 2026: Earnings due 11 Feb, watch guidance

Earnings for Dassault Systèmes SE (DSY.PA) are scheduled for 11 Feb 2026, and investors are watching subscription growth and guidance. Today intraday the DSY.PA stock trades at €22.25, down -2.24% on volume 3,804,887. Market focus is on recurring revenue trends and margin leverage in the Software – Application sector.

Earnings spotlight: what to watch in the 11 Feb release

Management commentary on ARR and subscription churn will move the DSY.PA stock price. Expect analysts to focus on growth in 3DEXPERIENCE and Medidata billings. Revenue trends matter: last twelve months revenue was €6.31B and quarterly revenue showed a slight decline per public data (StockAnalysis).

Price action and valuation snapshot for DSY.PA stock

DSY.PA is trading at €22.25 with a PE of 25.57 and EPS €0.87. The stock sits near its year low of €21.86 and well below its year high of €40.81. Volume today is elevated at 3,804,887, versus average volume 2,214,690, suggesting active positioning ahead of results.

Financials and growth metrics important to investors

Margins remain healthy: gross margin 80.97% and operating margin 21.38%. Free cash flow per share is €1.12 and cash per share is €2.96. Revenue growth was 4.41% year-over-year in 2024 and net income grew 14.21% in the latest fiscal year. These metrics help frame valuation versus the Technology sector average PE of 32.29.

Technical view, sector context and Meyka AI stock grade

Technically, RSI is 62.28 and MACD histogram is slightly positive, indicating mild bullish momentum. The Technology sector is up 4.36% YTD, which provides a supportive backdrop. Meyka AI rates DSY.PA with a score of 74.94 out of 100, Grade B+, suggestion BUY. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Grades are model outputs only and are not financial advice.

Risks and opportunities for DSY.PA stock

Key risks include slower enterprise license renewals and FX headwinds. Debt is modest with debt to equity 0.31, reducing refinancing risk. Opportunity lies in Medidata integration and cross-sell inside manufacturing and life sciences. Watch consensus guidance and any change to subscription margin targets during the call.

Outlook and price forecasts including Meyka AI model

Meyka AI’s forecast model projects a one-year price of €21.22, implying -4.63% versus the current €22.25. Shorter-term model outputs show monthly €21.06 and quarterly €17.75. For scenario planning, price targets are: conservative €18.00, base €24.00, bullish €30.00. Forecasts are model-based projections and not guarantees. For historical context and split history see Investing.com.

Final Thoughts

DSY.PA stock enters the 11 Feb 2026 earnings window with mixed signals. The company shows healthy margins and positive net income growth, yet the share trades near the year low at €22.25 and below the 200-day average €27.73. Meyka AI’s forecast model projects €21.22 in one year, an implied downside of -4.63% from the current price. That projection contrasts with our base price target of €24.00, which assumes stable subscription growth and modest margin expansion. Upside catalysts include stronger-than-expected Medidata revenue and clearer guidance on ARR expansion. Downside risks are slower enterprise renewals and macro-driven IT spend cuts. Use the earnings call to reassess guidance, the ARR cadence, and margin trajectory. For quick reference visit our Meyka stock page for DSY.PA: Meyka DSY.PA page. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.